Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis

BACKGROUND: Tacrolimus has been recommended as an effective immunosuppressant for patients with myasthenia gravis (MG), while the high price, variable bioavailability, and narrow therapeutic window restrict its clinical application. Wuzhi capsule (WZC) could improve tacrolimus blood concentration by...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yuyao, Jiang, Fei, Zhou, Ran, Jin, Wanlin, Li, Yi, Duan, Weiwei, Xu, Liqun, Yang, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286075/
https://www.ncbi.nlm.nih.gov/pubmed/34285488
http://dx.doi.org/10.2147/NDT.S319500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286075/
https://www.ncbi.nlm.nih.gov/pubmed/34285488
http://dx.doi.org/10.2147/NDT.S319500

Ejemplares similares